| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |